ArisInfra Solutions will launch its Rs 500 crore IPO from June 18–20, priced at Rs 210–222 per share. Backed by PharmEasy’s co-founder, the tech-driven B2B platform aims to use proceeds for working capital, tech upgrades, and expansion. Strong GMP indicates robust investor interest ahead of the June 25 listing.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets